Skip to content
value.today

Voxcell BioInnovation Inc.

Total raised
$3 M
2 rounds on record
Latest round
$2 M
Feb 2025
First round on record
Dec 2023
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Voxcell BioInnovation Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2025$2 MNo. 2Under $2 million

Voxcell BioInnovation Inc.: Raise no. 2, Feb 2025

Investors in this round

10 investors had bought by the notice of Mar 24, 2025: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$90,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in British Columbia, Canada

People named in the notice

  • Karolina Papera Valente · Executive Officer, Director
  • Mark Papera Miller · Director
  • Nina Papera Vellani · Director
  • Qi Papera Fang · Director
  • Robert Papera Levak · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amount of offering is CAD$2,500,000, and amount already sold is CAD$2,499,972.91. Amounts shown are based upon conversion to US Dollars at the time of this filing.”

Signed by Karolina Valente, Ceo. Newest notice filed Mar 24, 2025. Read the notice at the SEC.

equitySEC
Dec 2023$2 MNo. 1Under $2 million

Voxcell BioInnovation Inc.: Raise no. 1, Dec 2023

Investors in this round

38 investors had bought by the notice of Nov 18, 2024: 38 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$90,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in British Columbia, Canada

People named in the notice

  • Karolina Papera Valente · Executive Officer, Director
  • Mark Papera Miller · Director
  • Nina Papera Vellani · Director
  • Qi Papera Fang · Director
  • Robert Papera Levak · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amount of offering is CAD$2,750,000, and amount already sold is CAD$2,165,074.69. Amounts shown are based upon conversion to US Dollars at the time of this filing.”

Signed by Karolina Valente, Ceo. Newest notice filed Nov 18, 2024. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Voxcell BioInnovation Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2025).

    SEC Form D · Mar 2025

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Voxcell BioInnovation Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Voxcell BioInnovation Inc.
NameRoleNamed in
Karolina Papera ValenteExecutive officerMar 2025
Karolina Papera ValenteDirectorMar 2025
Mark Papera MillerDirectorMar 2025
Nina Papera VellaniDirectorMar 2025
Qi Papera FangDirectorMar 2025
Robert Papera LevakDirectorMar 2025